Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 1,297 | 17 | 120 | 14 |
| Gross Profit | 1,297 | 17 | 120 | 14 |
| Operating Expenses | 11,539 | 8,489 | 7,920 | 0 |
| Operating Income | -10,241 | -8,472 | -7,800 | 14 |
| Other Income | 1,001 | 194 | -18,930 | 0 |
| Pre-tax Income | -9,240 | -8,278 | -26,730 | 14 |
| Net Income Continuous | -9,240 | -8,278 | -7,261 | -3,616 |
| Net Income | $-9,240 | $-8,278 | $-26,730 | $-3,616 |
| EPS Basic Total Ops | -2.94 | -3.72 | -13.62 | -2.16 |
| EPS Basic Continuous Ops | -2.96 | -3.70 | -3.69 | -2.15 |
| EPS Diluted Total Ops | -2.94 | -3.72 | -13.62 | -2.16 |
| EPS Diluted Continuous Ops | -2.96 | -3.70 | -3.69 | -2.15 |
| EBITDA(a) | $-9,825 | $-8,159 | $-7,580 | $14 |